Priority Setting as an Ethical Imperative in Managing Global Dialysis Access and Improving Kidney Care

被引:34
作者
Luyckx, Valerie A. [1 ,2 ]
Moosa, M. Rafique [3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Renal Div, Boston, MA 02115 USA
[2] Univ Cape Town, Dept Child Hlth & Pediat, Cape Town, South Africa
[3] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Cape Town, South Africa
关键词
end-stage kidney failure; dialysis; transplant; low-resource settings; equity; universal health coverage; Priority setting; transparency; UNIVERSAL HEALTH COVERAGE; RENAL REPLACEMENT THERAPY; CHILDREN; EQUITY; HEMODIALYSIS; PERSPECTIVE; CHALLENGES; PRINCIPLES; THAILAND; POVERTY;
D O I
10.1016/j.semnephrol.2021.05.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Priority-setting dilemmas arise when trade-offs must be made regarding the kinds of services that should be provided and to whom, thereby withholding other services from individuals or groups that could benefit from them. Currently, it is practically impossible for lower-income countries to provide dialysis for all patients with kidney failure; however, the fundamental premise of the human right to health, while acknowledging the current resource constraints, is the progressive realization of access to care for all. In this article we outline the rationale for priority setting, starting with the global goal of achieving universal health coverage, the prerequisites for fair and transparent priority setting, and discuss how these may apply to expensive care such as dialysis. Priority is inherently a value-laden process, and cannot be whittled down to technical considerations of clinical or cost effectiveness alone. Fair and transparent priority setting should originate from population health needs, be based on evidence, and be associated with ethical values or principles. This requires effective engagement with relevant stakeholders. Once policies are developed and implemented, good oversight is crucial to ensure accountability and to provide iterative feedback such that the goals of universal health coverage may be progressively realized. Semin Nephrol 41:230-241 (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 241
页数:12
相关论文
共 83 条
[1]  
[Anonymous], MAK FAIR CHOIC PATH
[2]  
Ashuntantang G, 2017, LANCET GLOB HEALTH, V5, pE408, DOI [10.1016/S2214-109X(17)30057-8, 10.1016/s2214-109x(17)30057-8]
[3]   Priority-setting in healthcare: a framework for reasonable clinical judgements [J].
Baeroe, K. .
JOURNAL OF MEDICAL ETHICS, 2009, 35 (08) :488-496
[4]   Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness [J].
Baltussen, Rob ;
Jansen, Maarten P. ;
Mikkelsen, Evelinn ;
Tromp, Noor ;
Hontelez, Jan ;
Bijlmakers, Leon ;
Van der Wilt, Gert Jan .
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2016, 5 (11) :615-618
[5]   Rationing of Health Care in the United States An Inevitable Consequence of Increasing Health Care Costs [J].
Bauchner, Howard .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (08) :751-752
[6]   Making diagnostic tests as essential as medicines [J].
Berumen, Adriana Velazquez ;
Garner, Sarah ;
Hill, Suzanne Rose ;
Swaminathan, Soumya .
BMJ GLOBAL HEALTH, 2018, 3 (04)
[7]   The Equitable Distribution of COVID-19 Therapeutics and Vaccines [J].
Bollyky, Thomas J. ;
Gostin, Lawrence O. ;
Hamburg, Margaret A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (24) :2462-2463
[8]   Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy [J].
Bradshaw, Christina ;
Gracious, Noble ;
Narayanan, Ranjit ;
Narayanan, Sajith ;
Safeer, Mohammed ;
Nair, Geetha M. ;
Murlidharan, Praveen ;
Sundaresan, Aiswarya ;
Santhi, Syamraj Retnaraj ;
Prabhakaran, Dorairaj ;
Tamura, Manjula Kurella ;
Jha, Vivekanand ;
Chertow, Glenn M. ;
Jeemon, Panniyammakal ;
Anand, Shuchi .
KIDNEY INTERNATIONAL REPORTS, 2019, 4 (03) :390-398
[9]  
Braveman P, 2003, B WORLD HEALTH ORGAN, V81, P539
[10]   Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review [J].
Brouwer, Elizabeth D. ;
Watkins, David ;
Olson, Zachary ;
Goett, Jane ;
Nugent, Rachel ;
Levin, Carol .
BMC PUBLIC HEALTH, 2015, 15